Magazine article Business Asia

Proteome's Partner Strategy

Magazine article Business Asia

Proteome's Partner Strategy

Article excerpt

WHILE MOST Australian biotech companies are still scratching their heads in research labs, recently listed company Proteome Systems are making a name for themselves as an active global player in the new but increasingly important proteomics field.

Proteome Systems was born out of Macquarie University's Centre for Analytical Biotechnology in Sydney. The group specialises in producing platforms which have the capacity to conduct large-scale proteomics. In basic terms, proteomics involves separating, identifying and characterising the proteins present in tissue or other biological samples for the purpose of recognising and preventing disease. Proteomics is complementary to genome research (looking at and customising genes and DNA) and may have commercial potential in the future development of preventative drugs.

Proteome Systems chief executive officer and founder Keith Williams says his company is keen to develop a range of products that will support protein analysis and pioneer the commercialisation applications of proteomics.

"Proteomics is the next wave now that the genome has been sequenced," Williams said.

"But there hasn't been a huge number of products coming from DNA/gene structure information. At this stage, it's more a case of information you need to move to the next stage. We're involved in building the picks and shovels for the next level."

Williams may have only formed the business two years ago, but its strong position in the development of platform solutions for biotech businesses has already spread internationally.

One of the ways the group has achieved this is through its partnerships with larger, international biotech companies. Proteomics Systems' current alliances include US-based MicroFab Technologies, Swiss company GeneBio and the CSIRO. Proteome also announced an extension of the alliance between itself and Japanese scientific instrument manufacturer Shimadzu Corporation in December 2000, which will see two new proteomics facilities established in Sydney and Boston, USA. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.